These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 27887710)

  • 1. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens for preventing miscarriage: a network meta-analysis.
    Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.
    Haas DM; Hathaway TJ; Ramsey PS
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology.
    Haas DM; Hathaway TJ; Ramsey PS
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003511. PubMed ID: 30298541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta-analysis.
    Zhao Y; D'Souza R; Gao Y; Hao Q; Kallas-Silva L; Steen JP; Guyatt G
    Acta Obstet Gynecol Scand; 2024 Sep; 103(9):1689-1701. PubMed ID: 38481031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestogen for preventing miscarriage.
    Oates-Whitehead RM; Haas DM; Carrier JA
    Cochrane Database Syst Rev; 2003; (4):CD003511. PubMed ID: 14583982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003511. PubMed ID: 18425891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
    Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
    Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of progesterone on threatened miscarriage: Difference in drug types.
    Wang XX; Luo Q; Bai WP
    J Obstet Gynaecol Res; 2019 Apr; 45(4):794-802. PubMed ID: 30632226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogens and pregnancy loss.
    Carp HJA
    Climacteric; 2018 Aug; 21(4):380-384. PubMed ID: 29565684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
    Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
    Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials.
    Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V
    Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestogens in the prevention of miscarriage.
    Carp HJ
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):55-62. PubMed ID: 26677905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
    Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
    Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
    Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
    BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.
    Chan DM; Cheung KW; Yung SS; Lee VC; Li RH; Ng EH
    Trials; 2016 Aug; 17(1):408. PubMed ID: 27534747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.